期刊文献+

美他多辛联合多烯磷脂酰胆碱治疗酒精性肝病临床疗效观察 被引量:6

Observation on the clinical effect of metadoxine combined with polyene phosphatidylcholine for alcoholic liver disease
下载PDF
导出
摘要 目的探讨美他多辛联合多烯磷脂酰胆碱治疗酒精性肝病的临床疗效。方法 60例酒精性肝病(ALD)患者随机分为治疗组和对照组,每组30例。对照组在一般治疗基础上给予多烯磷脂酰胆碱;治疗组在对照组基础上给予美他多辛;疗程均为4周。检测2组治疗前后血清谷丙转氨酶(ALT),谷草转氨酶(AST),胆红素(TBil),谷酰转肽酶(GGT)水平,比较2组治疗后症状、体征改善情况和临床有效率。结果 2组治疗后血清ALT、AST、TBil、GGT水平均明显降低。治疗组治疗后血清ALT、AST、TBil、GGT水平明显低于对照组。2组治疗后症状、体征改善情况无显著差异。治疗组临床有效率明显高于对照组。结论美他多辛和多烯磷脂酰胆碱联用治疗酒精性肝病,疗效优于单用多烯磷脂酰胆碱。 Objective To explore the clinical effect of metadoxine combined with polyene phosphatidyl choline in the treatment of alcoholic liver disease. Methods Sixty patients with alco- holic liver disease (ALD) were randomly divided into treatment group and control group, 30 cases in each group. The control group received polyene phosphatidylcholine on the basis of general treat- ment. The treatment group received metadoxine on the basis of the control group. The courses of treatment of both groups were 4 weeks. The levels of serum alanine aminotransferase (ALT), as- partate aminotransferase (AST) total, bilirubin (TBil) and gamma-glutamyl transpeptidase (GGT) of two groups before and after treatment were detected. The symptoms, signs and clinical efficiency of two groups after treatment were compared. Results After treatment, the levels of ALT, AST, TBil and GGT in serum significantly reduced in two groups. After treatment, the levels of ALT, AST, TBil and GGT in serum of the treatment group were markedly lower than that of the control group. The improved conditions of symptoms and signs had no significant differences between two groups after treatment. The clinical efficacy rate of the treatment group was significantly higher than that of the control group. Conclusion The therapeutic effect of metadoxine combined with polyene phosphatidyl choline are superior to that of polyene phosphatidyl choline in the treatment of alcoholic liver disease.
作者 曹弘 汪铮
出处 《实用临床医药杂志》 CAS 2013年第1期89-91,共3页 Journal of Clinical Medicine in Practice
基金 中国高校医学期刊临床专项资金(11220267)
关键词 美他多辛 多烯磷脂酰胆碱 酒精性肝病 metadoxine polyene phosphatidylcholine alcoholic liver disease
  • 相关文献

参考文献12

  • 1厉有名,范建高,王炳元,陆伦根,施军平,牛俊奇,沈薇,徐有青,曾民德,贾继东,袁平戈.酒精性肝病诊疗指南[J].临床肝胆病杂志,2010,26(3):229-232. 被引量:117
  • 2茅益民,曾民德,陆伦根,王炳元,尚佳,施瑞华,刘吉勇,樊微,魏良洲,王青,汪素文,周海洋.美他多辛片治疗酒精性肝病的多中心、随机、双盲、安慰剂平行对照临床研究[J].肝脏,2006,11(5):303-306. 被引量:10
  • 3Shen J,Wong V W. Commentary:assessment of non-alcoholic fatty liver disease using scrum total cell death and apop tosis markers-authors' reply[J].Alimentary Pharmacology and Therapeutics,2013,(02):276.
  • 4Kharbanda K K. Methionine metabolic pathway in alcoholic liver injury[J].Current Opinion in Clinical Nutrition and Metabolic Care,2013,(01):89.
  • 5Bensamoun S F,Leclerc G E,Debemard L. Cutoff Values for Alcoholic Liver Fibrosis Using Magnetic Resonance Elastography Technique[J].Alcoholism:Clinical and Experimental Research,2012.
  • 6沈薇.非酒精性脂肪性肝病的药物治疗[J].中华肝脏病杂志,2003,11(2):114-114. 被引量:29
  • 7汪素文,周世庆,张伯新,田淑杰,倪永科.美他多辛治疗酒精性肝病的疗效观察[J].中国全科医学,2005,8(10):835-835. 被引量:8
  • 8戴德银.实用新药物手册[M]北京:人民军医出版社,2002845.
  • 9Shpilenya L S,Muzychenko A P,Gasbarrini G. Metadoxine in acute alcohol Intoxication:a double blind,randomized,placebo-controlled study[J].Alcoholism:Clinical and Experimental Research,2002,(03):340.
  • 10Diaz Maltinez M C,Diaz Maltinez A,Villamil Salcedo V. Efficacy of Metadoxine in the management of acute alcohol intoxication[J].Journal of International Medical Research,2002,(01):44.

二级参考文献26

共引文献157

同被引文献61

  • 1黄文丹.多烯磷脂酰胆碱联合美他多辛治疗酒精性肝病的临床分析[J].中国当代医药,2013,20(24):93-94. 被引量:5
  • 2连小兰,白耀,戴为信,金自孟,曾正陪,郭芝生.丙硫氧嘧啶导致症状性肝损伤的临床特征及相关因素分析[J].中华内科杂志,2004,43(6):442-446. 被引量:22
  • 3中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南[J].药品评价,2007,4(2):74-76. 被引量:26
  • 4Lazerow SK, Abdi MS, Lewis JH. Drug-induced liver dis- ease 2004 [ J ]. Curr Opin Gastroenterol ; 2005,21 ( 3 ) : 283- 292.
  • 5Kharbanda KK.Methionine metabolic pathway in alcoholic liver injury[J].Curr Opin Nutr Metab Care,2013,16(1):89.
  • 6Shen J,Wong VW.Commentary:assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers authors' reply[J].Aliment Pharmacol Ther,2013,37(2):276.
  • 7Kornek M,Lynch M,Mehta SH,et al.Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis[J].Gastroenterology,2012,143 (2):448-458.
  • 8Paz-Filho G,Mastronardi CA,Parker BJ,et al.Molecular pathways involved in the improvement of non-alcoholic fatty liver disease[J].J Mol Endocrinol,2013,51 (1):167-179.
  • 9Leggio L,Kenna GA,Ferrulli A,et al.Preliminary findings on the use of metadoxine for the treatment of alcohol dependence and alcoholic liver disease[J].Hum Psychopharmacol,2011,26(8):554-559.
  • 10Oniki K,Hori M,Saruwatari J,et al.Interactive effects of smoking and glutathione S-transferase polymorphisms on the development of non-alcoholic fatty liver disease[J].Toxicol Lett,2013,220(2):143-149.

引证文献6

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部